Amanote Research

Amanote Research

  • Register
  • Sign In

Nuclease-Resistant Synthetic Ribozymes: Developing a New Class of Therapeutics

Journal of Clinical Investigation- United States

doi 10.1172/jci11631

Full Text

Abstract

Available in

Categories

Medicine

Date

November 15, 2000

Authors

Nassim UsmanLawrence M. Blatt

Publisher

American Society for Clinical Investigation


Related search

Nuclease-Resistant Chimeric Ribozymes Containing Deoxyribonucleotides and Phosphorothioate Linkages

Nucleic Acids Research
Genetics
1993English

Developing a New Class of Engineered Live Bacterial Therapeutics to Treat Human Diseases

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Taurine Analogues: A New Class of Therapeutics

2012English

Developing Nuclease-Resistant DNA-Based Tension Sensor for Cellular Force Imaging

Biophysical Journal
Biophysics
2019English

How RNA Acts as a Nuclease: Some Mechanistic Comparisons in the Nucleolytic Ribozymes

Biochemical Society Transactions
Biochemistry
2017English

New Therapeutics to Treat Castrate-Resistant Prostate Cancer

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Synthetic Approaches Towards a New Class of Strained "Lactenediynes"

Arkivoc
Organic Chemistry
2006English

Reverse Transcription Using Nuclease Resistant Primers

Nucleic Acids Research
Genetics
1993English

P1 Nuclease Defines a Subpopulation of Active SV40 Chromatin—a New Nuclease Hypersensitivity Assay

Nucleic Acids Research
Genetics
1990English

Amanote Research

Note-taking for researchers

Follow Amanote


© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy